TGen
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit.
The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured.
Labs Launching Employer SARS-CoV-2 Testing Programs as Businesses Reopen
Launched by both national labs and regional and specialty firms, the offerings provide testing as well as guidance on how to best structure testing programs.